PMV Pharmaceuticals, Inc. Quarterly Assets in USD from Q4 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: PMV Pharmaceuticals, Inc. quarterly Assets history and growth rate from Q4 2019 to Q3 2024.
PMV Pharmaceuticals, Inc. Assets for the quarter ending September 30, 2024 was $223M, a 14.4% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$223M	-$37.5M	-14.4%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$238M	-$4.68M	-1.93%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$237M	-$17.1M	-6.73%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$252M	-$18.2M	-6.72%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$261M	-$24M	-8.41%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$242M	-$58.3M	-19.4%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$254M	-$61M	-19.4%	Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$270M	-$61.3M	-18.5%	Dec 31, 2022	10-K	2024-02-29
Q3 2022	$285M	-$59.2M	-17.2%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$301M	-$55.3M	-15.6%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$315M	-$39.4M	-11.1%	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$332M	-$34M	-9.29%	Dec 31, 2021	10-K	2023-03-01
Q3 2021	$344M	-$30.3M	-8.08%	Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$356M			Jun 30, 2021	10-Q	2021-08-13
Q1 2021	$354M			Mar 31, 2021	10-Q	2021-05-14
Q4 2020	$366M	+$262M	+255%	Dec 31, 2020	10-K	2022-03-01
Q3 2020	$374M			Sep 30, 2020	10-Q	2020-11-13
Q4 2019	$103M			Dec 31, 2019	10-K	2021-03-03

* An asterisk sign (*) next to the value indicates that the value is likely invalid.